I will buy some more on the dip but what really gets me is that they could've easily filled the book up with retail investors. I'd gladly buy 10-15% more of my holding at $1.60.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025